Cogent Biosciences, Inc.
COGT
$12.23
$0.443.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 12.39% | 1.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.87% | 1.63% | |||
| Operating Income | -0.87% | -1.63% | |||
| Income Before Tax | -2.14% | -5.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.14% | -5.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.14% | -5.98% | |||
| EBIT | -0.87% | -1.63% | |||
| EBITDA | -0.85% | -1.62% | |||
| EPS Basic | -1.10% | -4.17% | |||
| Normalized Basic EPS | -1.11% | -12.47% | |||
| EPS Diluted | -1.10% | -4.17% | |||
| Normalized Diluted EPS | -1.11% | -12.47% | |||
| Average Basic Shares Outstanding | 1.02% | 1.73% | |||
| Average Diluted Shares Outstanding | 1.02% | 1.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||